DE3871305D1 - Verwendung von einer immunstimulanten biologisten substanz zur herstellung eines medikaments zur behandlung des menschlichen immunschwaechevirus. - Google Patents
Verwendung von einer immunstimulanten biologisten substanz zur herstellung eines medikaments zur behandlung des menschlichen immunschwaechevirus.Info
- Publication number
- DE3871305D1 DE3871305D1 DE8888114582T DE3871305T DE3871305D1 DE 3871305 D1 DE3871305 D1 DE 3871305D1 DE 8888114582 T DE8888114582 T DE 8888114582T DE 3871305 T DE3871305 T DE 3871305T DE 3871305 D1 DE3871305 D1 DE 3871305D1
- Authority
- DE
- Germany
- Prior art keywords
- virus
- immunimimanial
- biologist
- detective
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000700605 Viruses Species 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 3
- 210000004027 cell Anatomy 0.000 abstract 2
- 210000002443 helper t lymphocyte Anatomy 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000003308 immunostimulating effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9955487A | 1987-09-22 | 1987-09-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3871305D1 true DE3871305D1 (de) | 1992-06-25 |
Family
ID=22275565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8888114582T Expired - Fee Related DE3871305D1 (de) | 1987-09-22 | 1988-09-07 | Verwendung von einer immunstimulanten biologisten substanz zur herstellung eines medikaments zur behandlung des menschlichen immunschwaechevirus. |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0308724B1 (de) |
AT (1) | ATE76302T1 (de) |
DE (1) | DE3871305D1 (de) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4572834A (en) * | 1984-04-10 | 1986-02-25 | Clinical Reference Laboratory, Inc. | Biologic and method of preparing same |
US4711876A (en) * | 1985-12-05 | 1987-12-08 | Catapano Salvatore J | Process for the treatment and remission of AIDS (acquired immune deficiency syndrome) |
-
1988
- 1988-09-07 AT AT88114582T patent/ATE76302T1/de not_active IP Right Cessation
- 1988-09-07 EP EP88114582A patent/EP0308724B1/de not_active Expired - Lifetime
- 1988-09-07 DE DE8888114582T patent/DE3871305D1/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0308724A3 (en) | 1990-01-31 |
EP0308724B1 (de) | 1992-05-20 |
EP0308724A2 (de) | 1989-03-29 |
ATE76302T1 (de) | 1992-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG17493G (en) | Ozone decontamination of blood and blood products | |
DE69202019D1 (de) | Verwendung von essentiellen Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von AIDS. | |
DE3684363D1 (de) | Phosphonylmethoxyalkyl-adeninen zur behandlung von viruskrankheiten. | |
ATA123791A (de) | Verfahren zur herstellung eines inaktivierten blutproduktes | |
ATE395922T1 (de) | Lipid-analoge zur behandlung von viralen infektionen | |
DE3784693D1 (de) | Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen. | |
HU901585D0 (en) | Method for treatment of viral infections using functional derivatives of icam-1 | |
SE9003198L (sv) | Fiskvaccin omfattande en virulent, invasiv bakterie | |
ATE78696T1 (de) | Arzneimittelzubereitung zur behandlung des immunmangels. | |
ATE148628T1 (de) | 5-methylisoxazol-4-carbonsäure-anilide und 2- hydroxyethyliden-cyanoessigsäure-anilide zur behandlung von augenkrankheiten | |
ATE106736T1 (de) | Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes. | |
ATE135223T1 (de) | Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose | |
DE3750886D1 (de) | Verwendung eines immunglobulinhaltigen Präparates zur Prophylaxe und Therapie von AIDS beim Menschen. | |
DE3871305D1 (de) | Verwendung von einer immunstimulanten biologisten substanz zur herstellung eines medikaments zur behandlung des menschlichen immunschwaechevirus. | |
DE3856052D1 (de) | Anwendung des N-n-butyl-Derivates von Desoxynojirimycin zur Herstellung eines Arzneimittels zur Inhibierung von HIV-Virus | |
DE3767308D1 (de) | Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels. | |
DE69428112T2 (de) | Verwendung von thymosin zur behandlung von hepatitis c bei patienten, die auf interferongaben nicht ansprechen | |
DE3873188D1 (de) | Verwendung von nigerizin zur herstellung eines mittels zur behandlung von virus-erkrankungen. | |
GR3001178T3 (en) | Process for the preparation of germ-killed or of attenuated virulence substances, and their use | |
ATE88752T1 (de) | Inaktivierung von human immunodeficiency virus (hiv) in proteinhaltigen loesungen durch phenole. | |
ATE135238T1 (de) | Zusammensetzung zur stabilisierung von blutplasma im laufe der pasteurisation | |
MX9201288A (es) | Metodo de tratamiento. | |
ATE255417T1 (de) | Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen | |
DE68924316D1 (de) | Menschliches Gamma-Interferon, Verfahren zu seiner Herstellung und seine Verwendung. | |
DE3877102D1 (de) | Methode fuer die behandlung von viraler gehirnentzuendung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |